Home > Cashflow Statement > VENUS REMEDIES

VENUS REMEDIES
Cashflow Statement

VENUS REMEDIES is part of below Screeners ↓
Best Quarterly Growth Small Cap Stocks
Best 1M Momentum Small Cap Stocks
COMMUNITY POLL
for VENUS REMEDIES
Please provide your vote to see the results

VENUS REMEDIES Last 5 Year Cashflow Statement History

[Consolidated]

Mar2025Mar2024Mar2023Mar2022Mar2021
Profit Before Tax₹62 Cr₹45 Cr₹38 Cr₹36 Cr₹25 Cr
Adjustment ₹15 Cr₹20 Cr₹23 Cr₹26 Cr₹22 Cr
Changes In working Capital ₹25 Cr₹-12 Cr₹-25 Cr₹-22 Cr₹61 Cr
Cash Flow after changes in Working Capital ₹101 Cr₹53 Cr₹37 Cr₹41 Cr₹108 Cr
Cash Flow from Operating Activities ₹86 Cr₹37 Cr₹37 Cr₹41 Cr₹132 Cr
Cash Flow from Investing Activities ₹-76 Cr₹-7.21 Cr₹-51 Cr₹-17 Cr₹56 Cr
Cash Flow from Financing Activities ₹-1.02 Cr₹-1.08 Cr₹-0.57 Cr₹-9.48 Cr₹-162 Cr
Net Cash Inflow / Outflow ₹9.18 Cr₹29 Cr₹-15 Cr₹15 Cr₹26 Cr
Opening Cash & Cash Equivalents ₹49 Cr₹21 Cr₹43 Cr₹29 Cr₹1.94 Cr
Cash & Cash Equivalent on Amalgamation / Take over / Merger -----
Cash & Cash Equivalent of Subsidiaries under liquidations -----
Translation adjustment on reserves / op cash balalces frgn subsidiaries -----
Effect of Foreign Exchange Fluctuations ₹-0.61 Cr₹-1.25 Cr₹-7.27 Cr₹-0.52 Cr₹0.85 Cr
Closing Cash & Cash Equivalent ₹58 Cr₹49 Cr₹21 Cr₹43 Cr₹29 Cr

Compare Cashflow Statement of peers of VENUS REMEDIES

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
VENUS REMEDIES ₹941.5 Cr 26.4% 54.1% 134.9% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹427,034.0 Cr 0.9% 5.3% 1.8% Stock Analytics
DIVIS LABORATORIES ₹169,211.0 Cr -2.3% -3.3% 12.2% Stock Analytics
TORRENT PHARMACEUTICALS ₹124,875.0 Cr -3.3% 2.8% 19.7% Stock Analytics
CIPLA ₹122,082.0 Cr -1.6% -9.2% 4.4% Stock Analytics
DR REDDYS LABORATORIES ₹103,873.0 Cr NA -3.5% 4.6% Stock Analytics


VENUS REMEDIES Share Price vs Sensex

Share Price Returns(%) 1 Week 1 Month 1 Year
VENUS REMEDIES

26.4%

54.1%

134.9%

SENSEX

0.8%

1%

9.9%


You may also like the below Video Courses